We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

Sandbox 20001

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 10: Line 10:
== Potential treatments and ways to minimize exposure to COVID-19 ==
== Potential treatments and ways to minimize exposure to COVID-19 ==
-
<html5media height=“360” width=“640”>https://www.youtube.com/embed/x0TeNNUsWYE</html5media><br>
+
<html5media height=“360” width=“640”>https://vimeo.com/395937110</html5media><br>
 +
 
 +
 
'''Nature's Vacuum Cleaner - Binding of ACh to AChE'''<br>
'''Nature's Vacuum Cleaner - Binding of ACh to AChE'''<br>
Movie by Richard Gillilan, Israel Silman & Joel L. Sussman
Movie by Richard Gillilan, Israel Silman & Joel L. Sussman
 +
 +
 +
 +
<html5media height=“360” width=“640”>https://www.youtube.
This is '''wikitext'''.
This is '''wikitext'''.

Revision as of 15:01, 24 March 2020

Coronavirus Disease 2019 (COVID-19)

COVID-19 surface spike (PDB entry 6vsb)

Drag the structure with the mouse to rotate

References

  1. 1.0 1.1 1.2 Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020 Feb 19. pii: science.abb2507. doi: 10.1126/science.abb2507. PMID:32075877 doi:http://dx.doi.org/10.1126/science.abb2507
  2. Gordon, et al. A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing: bioRxiv (online) 2020 http://doi.org/10.1101/2020.03.22.002386
  3. Gautret, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open- label non-randomized clinical trial: Intl J Antimcrob Agents (in press) 2020 http://dx.doi.org/10.1016/j.ijantimicag.2020.105949
  4. Gao, et al. Structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target: bioRxiv (online) 2020 https://doi.org/10.1101/2020.03.16.993386
  5. Jin, et al. Structure of Mpro from COVID-19 virus and discovery of its inhibitors: bioRxiv (online) 2020[1]
  6. Andersen, et al. The proximal origin of SARS-CoV-2: Nature Med (in press) 2020 http://dx.doi.org/10.1038/s41591-020-0820-9]
  7. Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science. 2020 Mar 4. pii: science.abb2762. doi: 10.1126/science.abb2762. PMID:32132184 doi:http://dx.doi.org/10.1126/science.abb2762
  8. Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020;14(1):58-60. doi: 10.5582/ddt.2020.01012. PMID:32147628 doi:http://dx.doi.org/10.5582/ddt.2020.01012
Personal tools